Protara Therapeutics (TARA) Change in Receivables (2014 - 2019)
Protara Therapeutics (TARA) recorded quarterly Change in Receivables of -$7000.0 in Q4 2019, down 40.0% quarter-over-quarter from -$5000.0 in Q3 2019, and up 86.54% on a YoY basis from -$3752.6 in Q4 2018.
Protara Therapeutics (TARA) Change in Receivables (2014 - 2019) Analysis & Trends
Protara Therapeutics' Change in Receivables history runs 6 years deep, the most recent figure standing at -$7000.0 for Q4 2019.
- In Q4 2019, Change in Receivables rose 86.54% year-over-year to -$7000.0; the TTM figure through Dec 2019 stood at -$17000.0 (up 65.31% YoY), while the FY2019 annual figure was -$17000.0, up 65.31% from the prior year.
- Change in Receivables was -$7000.0 for Q4 2019 at Protara Therapeutics, down from -$5000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $305000.0 in Q1 2015 to a low of -$182000.0 in Q4 2015.
- Historically, Change in Receivables has averaged $2111.1 across 5 years, with a median of -$3500.0 in 2017.
- Biggest YoY gain for Change in Receivables was 2133.33% in 2015; the steepest drop was 768.75% in 2015.
- A 5-year view of Change in Receivables shows it stood at -$182000.0 in 2015, then jumped by 139.56% to $72000.0 in 2016, then tumbled by 137.5% to -$27000.0 in 2017, then slumped by 92.59% to -$52000.0 in 2018, then jumped by 86.54% to -$7000.0 in 2019.
- The last three Change in Receivables figures came in at -$7000.0 (Q4 2019), -$5000.0 (Q3 2019), and -$20000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -4.08 Mn |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -7,000.00 |
| Dec 31, 2019 | -7,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Jun 30, 2017 | -3,000.00 |
| Jun 30, 2017 | -3,000.00 |